Rvw Wealth, LLC Abb Vie Inc. Transaction History

Rvw Wealth, LLC

$1.02 Billion
Q3 2024

A detailed history of Rvw Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rvw Wealth, LLC holds 5,113 shares of ABBV stock, worth $936,088. This represents 0.1% of its overall portfolio holdings.

Number of Shares

5,113

Previous 5,213 1.92%

Holding current value

$936,088

Previous $894,000 12.86%

% of portfolio

0.1%

Previous 0.09%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $16,384 - $19,933	-100 Reduced 1.92%	5,113 $1.01 Million
Q2 2024 Jul 08, 2024	BUY	$154.79 - $180.76 $15,479 - $18,076	100 Added 1.96%	5,213 $894,000
Q1 2024 Apr 05, 2024	BUY	$159.82 - $182.1 $1,598 - $1,821	10 Added 0.2%	5,113 $931,000
Q4 2023 Jan 08, 2024	SELL	$137.6 - $154.97 $2,339 - $2,634	-17 Reduced 0.33%	5,103 $790,000
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $10,820 - $12,526	-81 Reduced 1.56%	5,120 $763,000
Q2 2023 Jul 06, 2023	BUY	$132.51 - $164.9 $10,733 - $13,356	81 Added 1.58%	5,201 $700,000
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $200,863 - $231,324	-1,389 Reduced 21.34%	5,120 $815,000
Q4 2022 Jan 12, 2023	BUY	$138.31 - $165.87 $42,876 - $51,419	310 Added 5.0%	6,509 $0
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $13,421 - $15,393	100 Added 1.64%	6,199 $832,000
Q2 2022 Jul 13, 2022	SELL	$137.62 - $174.96 $2,752 - $3,499	-20 Reduced 0.33%	6,099 $934,000
Q1 2022 Apr 07, 2022	SELL	$131.98 - $163.75 $11,350 - $14,082	-86 Reduced 1.39%	6,119 $992,000
Q4 2021 Jan 11, 2022	BUY	$107.43 - $135.93 $128,701 - $162,844	1,198 Added 23.93%	6,205 $1 Million
Q3 2021 Oct 07, 2021	BUY	$106.4 - $120.78 $5,426 - $6,159	51 Added 1.03%	5,007 $1 Million
Q2 2020 Jul 13, 2020	BUY	$73.37 - $98.18 $363,621 - $486,580	4,956 New	4,956 $487,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rvw Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rvw Wealth, LLC with notifications on news.

Account